Explanatory Analysis of a Machine Learning Model to Identify Hypertrophic Cardiomyopathy Patients from EHR Using

Nasibeh Zanjirani Farahani1, Shivaram Poigai Arunachalam2, Divaakar Siva Baala Sundaram3

  • 1Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

Proceedings. IEEE International Conference on Bioinformatics and Biomedicine
|July 28, 2021
PubMed

Insights

Machine learning models using electronic health records can improve the diagnosis of hypertrophic cardiomyopathy (HCM), a leading cause of sudden cardiac death. This study developed a predictive model to aid physicians in identifying HCM patients more effectively.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart disease and a primary cause of sudden cardiac death in young adults.
  • Despite established risk factors and guidelines, HCM diagnosis and management remain suboptimal, leading to underdiagnosis.
  • Electronic health record (EHR) data offers potential for developing machine learning models to improve HCM diagnosis.

Purpose of the Study:

  • To develop and evaluate a novel predictive model using EHR billing codes for identifying patients with hypertrophic cardiomyopathy (HCM).
  • To assist physicians in diagnostic decision-making for HCM through data-driven insights.
  • To explore the utility of automated phenotyping using billing codes for HCM detection.

Main Methods:

  • A cohort of 11,562 patients with suspected or confirmed HCM from 1995-2019 was analyzed.
  • Billing codes were extracted from EHR data, and ground truth labels were established using echocardiography or cardiac magnetic resonance imaging.
  • A random forest model was employed to predict HCM status ('definite HCM', 'possible HCM', 'no HCM phenotype').

Main Results:

  • The random forest model achieved an accuracy of 71%, weighted recall of 70%, precision of 75%, and weighted F1 score of 72% in identifying HCM patients.
  • The model demonstrated effectiveness in classifying patients across 'definite HCM', 'possible HCM', and 'no HCM phenotype' categories.
  • Multidimensional scaling and principal component analysis visualizations were generated to aid clinician interpretation.

Conclusions:

  • Billing codes within EHR data can be effectively utilized by machine learning models to identify patients with hypertrophic cardiomyopathy (HCM).
  • The developed predictive model shows promise in supporting clinical diagnosis and improving patient management for HCM.
  • This approach offers a valuable tool for enhancing the identification of HCM through automated EHR phenotyping.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
101
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
73
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
140
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
114
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
87